![Petter Veiby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Petter Veiby
Founder at
ATTOVIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-08-30
Profile
Mr. Petter Veiby is a Chief Scientific Officer at Attovia Therapeutics, Inc. He is on the Board of Directors at BiVictriX Therapeutics Plc.
Mr. Veiby was previously employed as a Senior Director by Takeda Oncology Co., a Senior Vice President-Business Development by Immunitas Therapeutics, Inc., a Head-Alliances by Zai Lab Ltd., and a Global Head-Biotherapeutics by Takeda Oncology Co.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-04 | 104,952 ( 0.23% ) | 2 M $ | 2026-08-30 |
Petter Veiby active positions
| Companies | Position | Start |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Founder | 2022-12-15 |
| BIVICTRIX THERAPEUTICS PLC | Director/Board Member | 2025-07-31 |
Former positions of Petter Veiby
| Companies | Position | End |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Director/Board Member | 2023-05-31 |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 2022-10-31 |
| ZAI LAB LIMITED | Corporate Officer/Principal | 2022-04-30 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 2020-02-29 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
- Stock Market
- Insiders
- Petter Veiby
